Acute management of intracranial hemorrhage in patients receiving thrombolytic therapy: case reports.
Intracranial hemorrhage is an uncommon complication of antithrombotic therapy. We present two patients who suffered life-threatening intracranial bleeding as a complication of thrombolytic/anticoagulant treatment. Early diagnosis and treatment appear to be crucial factors for survival. We suggest an approach to perioperative management for intracranial hemorrhage resulting from antithrombotic therapy.
Eleff
S M
SM
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland.
Borel
C
C
Bell
W R
WR
Long
D M
DM
D000368:Aged; D002543:Cerebral Hemorrhage / Q000209:etiology* / Q000601:surgery; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013300:Streptokinase / Q000009:adverse effects*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects*
D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator